Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Alberts, DS' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 138 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Alberts, DS; Hallum, AV; Stratton-Custis, M; Garcia, DJ; Gleason-Guzman, M; Salmon, SE; Santabarbara, P; Niesor, EJ; Floret, S; Bentzen, CL
      Phase I pharmacokinetic trial and correlative in vitro phase II tumor kinetic study of apomine (SR-45023A), a novel oral biphosphonate anticancer drug

      CLINICAL CANCER RESEARCH
    2. Chow, HHS; Cai, Y; Alberts, DS; Hakim, I; Dorr, R; Shahi, F; Crowell, JA; Yang, CS; Hara, Y
      Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenon E

      CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
    3. Waltmire, CN; Alberts, DS; Dorr, RT
      Sequence-dependent cytotoxicity of combination chemotherapy using paclitaxel, carboplatin and bleomycin in human lung and ovarian cancer

      ANTI-CANCER DRUGS
    4. Dorr, RT; Liddil, JD; Sami, SM; Remers, W; Hersh, EM; Alberts, DS
      Preclinical antitumor activity of the azonafide series of anthracene-basedDNA intercalators

      ANTI-CANCER DRUGS
    5. Alberts, DS
      Is there a role for intraperitoneal chemotherapy in the management of ovarian cancer? The Markman article reviewed

      ONCOLOGY-NEW YORK
    6. Bozzo, P; Alberts, DS; Vaught, L; da Silva, VD; Thompson, D; Warnecke, J; Miller, RC; Einspahr, J; Bartels, PH
      Measurement of chemopreventive efficacy in skin biopsies

      ANALYTICAL AND QUANTITATIVE CYTOLOGY AND HISTOLOGY
    7. Garcia, FAR; Davis, JR; Alberts, DS; Hatch, K; Weyn, B; Thompson, D; Bartels, PH
      Nuclear chromatin patterns in normal, hyperplastic and atypical endometrium

      ANALYTICAL AND QUANTITATIVE CYTOLOGY AND HISTOLOGY
    8. Bartels, PH; Garcia, FAR; Davis, J; da Silva, VD; Bartels, HG; Thompson, D; Alberts, DS
      Progression curves for endometrial lesions

      ANALYTICAL AND QUANTITATIVE CYTOLOGY AND HISTOLOGY
    9. Markman, M; Bundy, BN; Alberts, DS; Fowler, JM; Clark-Pearson, DL; Carson, LF; Wadler, S; Sickel, J
      Phase III trial of standard-dose intravenous cisplatin plus paclitaxel versus moderately high-dose carboplatin followed by intravenous paclitaxel andintraperitoneal cisplatin in small-volume stage III ovarian carcinoma: An intergroup study of the Gynecologic Oncology Group, Southwestern Oncology Group, and Eastern Cooperative Oncology Group

      JOURNAL OF CLINICAL ONCOLOGY
    10. Rothenberg, ML; Liu, PY; Wilczynski, S; Hannigan, EV; Weiner, SA; Weiss, GR; Hunter, VJ; Chapman, JA; Tiersten, A; Kohler, PC; Alberts, DS
      Phase II trial of oral altretamine for consolidation of clinical complete remission in women with stage III epithelial ovarian cancer: A Southwest Oncology Group trial (SWOG-9326)

      GYNECOLOGIC ONCOLOGY
    11. Foote, JA; Harris, RB; Giuliano, AR; Roe, DJ; Moon, TE; Cartmel, B; Alberts, DS
      Predictors for cutaneous basal- and squamous-cell carcinoma among actinically damaged adults

      INTERNATIONAL JOURNAL OF CANCER
    12. Maltzman, T; Knoll, K; Martinez, ME; Byers, T; Stevens, BR; Marshall, JR; Reid, ME; Einspahr, J; Hart, N; Bhattacharyya, AK; Kramer, CB; Sampliner, R; Alberts, DS; Ahnen, DJ
      Ki-ras proto-oncogene mutations in sporadic colorectal adenomas: Relationship to histologic and clinical characteristics

      GASTROENTEROLOGY
    13. Martinez, ME; Sampliner, R; Marshall, JR; Bhattacharyya, AK; Reid, ME; Alberts, DS
      Adenoma characteristics as risk factors for recurrence of advanced adenomas

      GASTROENTEROLOGY
    14. Xu, XC; Wong, WYL; Goldberg, L; Baer, SC; Wolf, JE; Ramsdell, WM; Alberts, DS; Lippman, SM; Lotan, R
      Progressive decreases in nuclear retinoid receptors during skin squamous carcinogenesis

      CANCER RESEARCH
    15. Samimi, G; Fink, D; Varki, NM; Husain, A; Hoskins, WJ; Alberts, DS; Howell, SB
      Analysis of MLH1 and MSH2 expression in ovarian cancer before and after platinum drug-based chemotherapy

      CLINICAL CANCER RESEARCH
    16. Chow, HHS; Earnest, DL; Clark, D; Mason-Liddil, N; Kramer, CB; Einspahr, JG; Guillen-Rodriguez, JM; Roe, DJ; Malone, W; Crowell, JA; Alberts, DS
      Effect of subacute ibuprofen dosing on rectal mucosal prostaglandin E-2 levels in healthy subjects with a history of resected polyps

      CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
    17. Alberts, DS; Dorr, RT; Einspahr, JG; Aickin, M; Saboda, K; Xu, MJ; Peng, YM; Goldman, R; Foote, JA; Warneke, JA; Salasche, S; Roe, DJ; Bowden, GT
      Chemoprevention of human actinic keratoses by topical 2-(difluoromethyl)-dl-ornithine

      CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
    18. Calaluce, R; Earnest, DL; Heddens, D; Einspahr, JG; Roe, D; Bogert, CL; Marshall, JR; Alberts, DS
      Effects of piroxicam on prostaglandin E-2 levels in rectal mucosa of adenomatous polyp patients: A randomized phase IIb trial

      CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
    19. Simon, R; Desper, R; Papadimitriou, CH; Peng, A; Alberts, DS; Taetle, R; Trent, JM; Schaffer, AA
      Chromosome abnormalities in ovarian adenocarcinoma: III. Using breakpoint data to infer and test mathematical models for oncogenesis

      GENES CHROMOSOMES & CANCER
    20. Stratton, SP; Dorr, RT; Alberts, DS
      The state-of-the-art in chemoprevention of skin cancer

      EUROPEAN JOURNAL OF CANCER
    21. Peters, WA; Liu, PY; Barrett, RJ; Stock, RJ; Monk, BJ; Berek, JS; Souhami, L; Grigsby, P; Gordon, W; Alberts, DS
      Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix

      JOURNAL OF CLINICAL ONCOLOGY
    22. Monsky, WL; Heddens, DK; Clark, GM; Von Hoff, DD; Coltman, CA; Dorr, RT; Alberts, DS
      Comparison of young clinical investigators' accuracy and reproducibility when measuring pulmonary and skin surface nodules using a circumferential measurement versus a standard caliper measurement: American Association for Cancer Research/American Society of Clinical Oncology Clinical Trials Workshop

      JOURNAL OF CLINICAL ONCOLOGY
    23. Lopez, AM; Ketchum, M; Nichols, H; Xu, MJ; Peng, YM; Dorr, R; Alberts, DS
      A phase I trial of AUC-directed carboplatin with infusional doxorubicin and ifosfamide plus G-CSF in patients with advanced gynecologic malignancies

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    24. Stratton, SP; Bangert, JL; Alberts, DS; Dorr, RT
      Dermal toxicity of topical (-)epigallocatechin-3-gallate in BALB/c and SKH1 mice

      CANCER LETTERS
    25. Dorr, RT; Dvorakova, K; Brooks, C; Lines, R; Levine, N; Schram, K; Miketova, P; Hruby, V; Alberts, DS
      Increased eumelanin expression and tanning is induced by a superpotent melanotropin [Nle(4)-D-Phe(7)]-alpha-MSH in humans

      PHOTOCHEMISTRY AND PHOTOBIOLOGY
    26. Alberts, DS; Martinez, ME; Marshall, JR
      High-fiber diet and colorectal adenomas

      NEW ENGLAND JOURNAL OF MEDICINE
    27. Alberts, DS; Martinez, ME; Roe, DJ; Guillen-Rodriguez, JM; Marshall, JR; van Leeuwen, JB; Reid, ME; Ritenbaugh, C; Vargas, PA; Bhattacharyya, AB; Earnest, DL; Sampliner, RE; Parish, D; Koonce, K; Fales, L
      Lack of effect of a high-fiber cereal supplement on the recurrence of colorectal adenomas

      NEW ENGLAND JOURNAL OF MEDICINE
    28. Sami, SM; Dorr, RT; Alberts, DS; Solyom, AM; Remers, WA
      Analogues of amonafide and azonafide with novel ring systems

      JOURNAL OF MEDICINAL CHEMISTRY
    29. Alberts, DS; Garcia, DJ; Fisher, E; Liu, PY
      Southwest Oncology Group experience with intraperitoneal chemotherapy of ovarian cancer

      REGIONAL CHEMOTHERAPY
    30. Cheng, L; Guan, YL; Li, L; Legerski, RJ; Einspahr, J; Bangert, J; Alberts, DS; Wei, QY
      Expression in normal human tissues of five nucleotide excision repair genes measured simultaneously by multiplex reverse transcription-polymerase chain reaction

      CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
    31. Martinez, ME; Marshall, JR; Graver, E; Whitacre, RC; Woolf, K; Ritenbaugh, C; Alberts, DS
      Reliability and validity of a self-administered food frequency questionnaire in a chemoprevention trial of adenoma recurrence

      CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
    32. Taetle, R; Aickin, M; Yang, LM; Panda, L; Emerson, J; Roe, D; Adair, L; Thompson, F; Liu, Y; Wisner, L; Davis, JR; Trent, J; Alberts, DS
      Chromosome abnormalities in ovarian adenocarcinoma: I. Nonrandom chromosome abnormalities from 244 cases

      GENES CHROMOSOMES & CANCER
    33. Levine, N; Dorr, RT; Ertl, GA; Brooks, C; Alberts, DS
      Effects of a potent synthetic melanotropin, Nle(4)-D-Phe(7)-alpha-MSH (Melanotan-1) on tanning: a dose-ranging study

      JOURNAL OF DERMATOLOGICAL TREATMENT
    34. Alberts, DS
      A unifying vision of cancer therapy for the 21st century

      JOURNAL OF CLINICAL ONCOLOGY
    35. Lopez, AM; Wallace, L; Dorr, RT; Koff, M; Hersh, EM; Alberts, DS
      Topical DMSO treatment for pegylated liposomal doxorubicin-induced palmar-plantar erythrodysesthesia

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    36. Dvorakova, K; Dorr, RT; Valcic, S; Timmermann, B; Alberts, DS
      Pharmacokinetics of the green tea derivative, EGCG, by the topical route of administration in mouse and human skin

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    37. Alberts, DS
      Protection by amifostine of cyclophosphamide-induced myelosuppression

      SEMINARS IN ONCOLOGY
    38. Alberts, DS
      Future directions in gynecologic cancer

      SEMINARS IN ONCOLOGY
    39. Alberts, DS
      Treatment of refractory and recurrent ovarian cancer

      SEMINARS IN ONCOLOGY
    40. Poplin, EA; Liu, PY; Delmore, JE; Wilczynski, S; Moore, DF; Potkul, RK; Fine, BA; Hannigan, EV; Alberts, DS
      Phase II trial of oral etoposide in recurrent or refractory endometrial adenocarcinoma: A Southwest Oncology Group study

      GYNECOLOGIC ONCOLOGY
    41. Batta, AK; Datta, SC; Tint, GS; Alberts, DS; Earnest, DL; Salen, G
      A convenient synthesis of dinorbile acids: Oxidative hydrolysis of norbileacid nitriles

      STEROIDS
    42. Iyengar, BS; Dorr, RT; Alberts, DS; Hersh, EM; Salmon, SE; Remers, WA
      Novel antitumor 2-cyanoaziridine-1-carboxamides

      JOURNAL OF MEDICINAL CHEMISTRY
    43. Martinez, ME; Maltzman, T; Marshall, JR; Einspahr, J; Reid, ME; Sampliner, R; Ahnen, DJ; Hamilton, SR; Alberts, DS
      Risk factors for Ki-ras protooncogene mutation in sporadic colorectal adenomas

      CANCER RESEARCH
    44. Alberts, DS; Colvin, GM; Conney, AH; Ernster, VL; Garber, JE; Greenwald, P; Gudas, LJ; Hong, WK; Kelloff, GJ; Kramer, RA; Lerman, CE; Mangelsdorf, DJ; Matter, A; Minna, JD; Nelson, WG; Pezzuto, JM; Prendergast, F; Rusch, VW; Sporn, MB; Wattenberg, LW; Weinstein, IB
      Prevention of cancer in the next millennium: Report of the ChemopreventionWorking Group to the American Association for Cancer Research

      CANCER RESEARCH
    45. Martinez, ME; Heddens, D; Earnest, DL; Bogert, CL; Roe, D; Einspahr, J; Marshall, JR; Alberts, DS
      Physical activity, body mass index, and prostaglandin E-2 levels in rectalmucosa

      JOURNAL OF THE NATIONAL CANCER INSTITUTE
    46. ALBERTS DS
      TUMOR HETEROGENEITY AND EXTREME DRUG-RESISTANCE - MEET YOUR MATCH

      The cancer journal from Scientific American
    47. MARTINEZ ME; REID ME; GUILLENRODRIGUEZ J; MARSHALL JR; SAMPLINER R; AICKIN M; RITENBAUGH C; VANLEEUWEN B; MASONLIDDIL N; GIULIANO A; VARGAS PA; ALBERTS DS
      DESIGN AND BASE-LINE CHARACTERISTICS OF STUDY PARTICIPANTS IN THE WHEAT BRAN FIBER TRIAL

      Cancer epidemiology, biomarkers & prevention
    48. BOZZO PD; VAUGHT LC; ALBERTS DS; THOMPSON D; BARTELS PH
      NUCLEAR MORPHOMETRY IN SOLAR KERATOSIS

      Analytical and quantitative cytology and histology
    49. Weiss, GR; Liu, PY; Alberts, DS; Peng, YM; Fisher, E; Xu, MJ; Scudder, SA; Baker, LH; Moore, DF; Lippman, SM
      13-cis-retinoic acid or all-trans-retinoic acid plus inteferon-alpha in recurrent cervical cancer: A Southwest Oncology Group phase II randomized trial

      GYNECOLOGIC ONCOLOGY
    50. Monk, BJ; Alberts, DS; Burger, RA; Fanta, PT; Hallum, AV; Hatch, KD; Salmon, SE
      In vitro phase II comparison of the cytotoxicity of a novel platinum analog, nedaplatin (254-S), with that of cisplatin and carboplatin against fresh, human cervical cancers

      GYNECOLOGIC ONCOLOGY
    51. MARTINEZ JD; STRATAGOULES ED; PAYNE CM; BATTA AK; CRAVEN MT; REID M; ALBERTS DS; POWELL AA; POWELL MB; EARNEST D
      THE TUMOR PROMOTER DEOXYCHOLIC-ACID INDUCES APOPTOSIS WHILE THE CHEMOPREVENTIVE AGENT URSODEOXYCHOLIC ACID INHIBITS CELL-PROLIFERATION

      Gastroenterology
    52. EARNEST DL; REID M; HEDDENS D; BATTA AK; SALEN G; ALBERTS DS; MORALES T
      TREATMENT WITH 600 MG DAY OF URSODEOXYCHOLIC ACID MAXIMALLY SUPPRESSES THE PROPORTION OF DEOXCHOLIC ACID IN FECAL WATER/

      Gastroenterology
    53. ALBERTS DS; SLATTERY ML; GIOVANNUCCI E; SHIKE M; GARCIA DJ
      PRIMARY PREVENTION OF COLON-CANCER WITH DIETARY AND MICRONUTRIENT INTERVENTIONS

      Cancer
    54. AABO K; ADAMS M; ADNITT P; ALBERTS DS; ATHANAZZIOU A; BARLEY V; BELL DR; BIANCHI U; BOLIS G; BRADY MF; BRODOVSKY HS; BRUCKNER H; BUYSE M; CANETTA R; CHYLAK V; COHEN CJ; COLOMBO N; CONTE PF; CROWTHER D; EDMONSON JH; GENNATAS C; GILBEY E; GORE M; GUTHRIE D; KAYE SB; LAING AH; LANDONI F; LEONARD RC; LEWIS C; LIU PY; MANGIONI C; MARSONI S; MEERPOHL H; OMURA GA; PARMAR MKB; PATER J; PECORELLI S; PRESTI M; SAUERBREI W; SKARLOS DV; SMALLEY RV; SOLOMON HJ; STEWART LA; STURGEON JFG; TATTERSALL MHN; WHARTON JT; HUININK WWT; TOMIROTTI M; TORRI W; TROPE C; TURBOW MM; VERMORKEN JB; WEBB MJ; WILBUR DW; WILLIAMS CJ; WILTSHAW E; YEAP BY
      CHEMOTHERAPY IN ADVANCED OVARIAN-CANCER - 4 SYSTEMATIC METAANALYSES OF INDIVIDUAL PATIENT DATA FROM 39 RANDOMIZED TRIALS

      British Journal of Cancer
    55. MARTINEZ ME; MATZMAN T; MARSHALL JR; EINSPAHR J; REID M; GUILLENRODRIGUEZ J; VANLEEUWEN B; AHNEN DJ; ALBERTS DS
      ASSOCIATION BETWEEN CIGARETTE-SMOKING AND K-RAS MUTATIONS IN COLORECTAL ADENOMAS

      American journal of epidemiology
    56. EINSPAHR J; ALBERTS DS; AICKIN M; WELCH K; BOZZO P; GROGAN T; NELSON M
      EXPRESSION OF P53 PROTEIN IN ACTINIC KERATOSIS, ADJACENT, NORMAL-APPEARING, AND NON-SUN-EXPOSED HUMAN SKIN

      Cancer epidemiology, biomarkers & prevention
    57. RITENBAUGH C; AICKIN M; TAREN D; TEUFEL N; GRAVER E; WOOLF K; ALBERTS DS
      USE OF A FOOD FREQUENCY QUESTIONNAIRE TO SCREEN FOR DIETARY ELIGIBILITY IN A RANDOMIZED CANCER PREVENTION PHASE-III TRIAL

      Cancer epidemiology, biomarkers & prevention
    58. ALBERTS DS; EINSPAHR J; RITENBAUGH C; AICKIN M; REESMCGEE S; ATWOOD J; EMERSON S; MASONLIDDIL N; BETTINGER L; PATEL J; BELLAPRAVALU S; RAMANUJAM PS; PHELPS J; CLARK L
      THE EFFECT OF WHEAT BRAN FIBER AND CALCIUM SUPPLEMENTATION ON RECTAL MUCOSAL PROLIFERATION RATES IN PATIENTS WITH RESECTED ADENOMATOUS COLORECTAL POLYPS

      Cancer epidemiology, biomarkers & prevention
    59. MOON TE; LEVINE N; CARTMEL B; BANGERT JL; RODNEY S; DONG Q; PENG YM; ALBERTS DS
      EFFECT OF RETINOL IN PREVENTING SQUAMOUS-CELL SKIN-CANCER IN MODERATE-RISK SUBJECTS - A RANDOMIZED, DOUBLE-BLIND, CONTROLLED TRIAL

      Cancer epidemiology, biomarkers & prevention
    60. LEVINE N; MOON TE; CARTMEL B; BANGERT JL; RODNEY S; DONG Q; PENG YM; ALBERTS DS
      TRIAL OF RETINOL AND ISOTRETINOIN IN SKIN-CANCER PREVENTION - A RANDOMIZED, DOUBLE-BLIND, CONTROLLED TRIAL

      Cancer epidemiology, biomarkers & prevention
    61. EINSPAHR JG; ALBERTS DS; GAPSTUR SM; BOSTICK RM; EMERSON SS; GERNER EW
      SURROGATE END-POINT BIOMARKERS AS MEASURES OF COLON-CANCER RISK AND THEIR USE IN CANCER CHEMOPREVENTION TRIALS

      Cancer epidemiology, biomarkers & prevention
    62. ALBERTS DS; FANTA PT; RUNNING KL; ADAIR LP; GARCIA DJ; LIUSTEVENS R; SALMON SE
      IN-VITRO PHASE-II COMPARISON OF THE CYTOTOXICITY OF A NOVEL PLATINUM ANALOG, NEDAPLATIN (254-S), WITH THAT OF CISPLATIN AND CARBOPLATIN AGAINST FRESH, HUMAN OVARIAN CANCERS

      Cancer chemotherapy and pharmacology
    63. MACDONALD JS; BENEDETTI JK; MODIANO M; ALBERTS DS
      PHASE-II EVALUATION OF TOPOTECAN IN PATIENTS WITH ADVANCED COLORECTAL-CANCER - A SOUTHWEST-ONCOLOGY-GROUP TRIAL (SWOG-9241)

      Investigational new drugs
    64. THOMPSON FH; TAETLE R; TRENT JM; LIU Y; MASSEYBROWN K; SCOTT KM; WEINSTEIN RS; EMERSON JC; ALBERTS DS; NELSON MA
      BAND 1P36 ABNORMALITIES AND T(1-17) IN OVARIAN-CARCINOMA

      Cancer genetics and cytogenetics
    65. ALBERTS DS
      TREATMENT OF OVARIAN-CANCER WITH INTRAPERITONEAL CISPLATIN - REPLY

      The New England journal of medicine
    66. IYENGAR BS; DORR RT; ALBERTS DS; SOLYOM AM; KRUTZSCH M; REMERS WA
      1,4-DISUBSTITUTED ANTHRACENE ANTITUMOR AGENTS

      Journal of medicinal chemistry
    67. SAMI SM; DORR RT; ALBERTS DS; SOLYOM AM; REMERS WA
      1,2-DIHYDRO-3H-DIBENZ[DE,H]ISOQUINOLINE-1,3-DIONES WITH SUBSTITUENTS AT POSITION-4, POSITION-8, POSITION-9, POSITION-10, AND POSITION-11 - SYNTHESIS, ANTITUMOR-ACTIVITY, AND QUANTITATIVE STRUCTURE-ACTIVITY-RELATIONSHIPS (VOL 39, PG 4978, 1996)

      Journal of medicinal chemistry
    68. DISARIO JA; ALBERTS DS; TIETZE CC; KHULLAR SK; BOHMAN VD; LARSEN BR; HIXSON LJ; SAMOWITZ WS; READING JC; BUYS SS; DAWSON R; BURT RW
      SULINDAC INDUCES REGRESSION AND PREVENTS PROGRESSION OF SPORADIC COLORECTAL ADENOMAS

      Gastroenterology
    69. ALBERTS DS; GARCIA DJ
      SAFETY ASPECTS OF PEGYLATED LIPOSOMAL DOXORUBICIN IN PATIENTS WITH CANCER

      Drugs
    70. PIAZZA GA; ALBERTS DS; HIXSON LJ; PARANKA NS; LI H; FINN T; BOGERT C; GUILLEN JM; BRENDEL K; GROSS PH; SPERL G; RITCHIE J; BURT RW; ELLSWORTH L; AHNEN DJ; PAMUKCU R
      SULINDAC SULFONE INHIBITS AZOXYMETHANE-INDUCED COLON CARCINOGENESIS IN RATS WITHOUT REDUCING PROSTAGLANDIN LEVELS

      Cancer research
    71. MARSHALL JR; ALBERTS DS; SAMPLINER RE
      COLON-CANCER REDUCTION - QUESTIONS ABOUT IMPLEMENTATION OF PROVEN TECHNIQUES

      Archives of internal medicine
    72. TRICOT G; ALBERTS DS; JOHNSON C; ROE DJ; DORR RT; BRACY D; VESOLE DH; JAGANNATH S; MEYERS R; BARLOGIE B
      SAFETY OF AUTOTRANSPLANTS WITH HIGH-DOSE MELPHALAN IN RENAL-FAILURE -A PHARMACOKINETIC AND TOXICITY STUDY

      Clinical cancer research
    73. EINSPAHR J; ALBERTS DS; AICKIN M; WELCH K; BOZZO P; LEVINE N; GROGAN T
      EVALUATION OF PROLIFERATING CELL NUCLEAR ANTIGEN AS A SURROGATE END-POINT BIOMARKER IN ACTINIC KERATOSIS AND ADJACENT, NORMAL-APPEARING, AND NON-SUN-EXPOSED HUMAN SKIN SAMPLES

      Cancer epidemiology, biomarkers & prevention
    74. ROE DJ; ALBERTS DS; WARGOVICH MJ; BOSTICK RM; GAREWAL HS; EINSPAHR J; FOSDICK L; RAMSEY L; WOODS C; MCGEE DL
      REPRODUCIBILITY OF THE MEASUREMENT OF COLONIC PROLIFERATION USING BROMODEOXYURIDINE ACROSS LABORATORIES

      Cancer epidemiology, biomarkers & prevention
    75. RITENBAUGH C; PENG YM; AICKIN M; GRAVER E; BRANCH M; ALBERTS DS
      NEW CAROTENOID VALUES FOR FOODS IMPROVE RELATIONSHIP OF FOOD FREQUENCY QUESTIONNAIRE INTAKE ESTIMATES TO PLASMA VALUES

      Cancer epidemiology, biomarkers & prevention
    76. ALBERTS DS; LIU PY; HANNIGAN EV; OTOOLE R; WILLIAMS SD; YOUNG JA; FRANKLIN EW; CLARKEPEARSON DL; MALVIYA VK; DUBESHTER B; HOSKINS WJ; ADELSON MD; ALVAREZ RD; OSULLIVAN J; GARCIA DJ; SPARKS DB; QUADE J; ROTHENBERG ML
      PHASE-III STUDY OF INTRAPERITONEAL CISPLATIN-INTRAVENOUS CYCLOPHOSPHAMIDE VERSUS INTRAVENOUS CISPLATIN-INTRAVENOUS CYCLOPHOSPHAMIDE IN PATIENTS WITH OPTIMAL DISEASE STAGE-III OVARIAN-CANCER - A SWOG-GOG-ECOG INTERGROUP STUDY

      International journal of gynecological cancer
    77. AICKIN M; ALBERTS DS
      THE MEASUREMENT OF ADENOMA OCCURRENCE

      European journal of cancer prevention
    78. ALBERTS DS; SPEICHER LA; KRUTZSCH M; WYMER J; CAPIZZI RL; CONLON J; BARRETT A; AICKIN M
      WR-1065, THE ACTIVE METABOLITE OF AMIFOSTINE (ETHYOL(R)), DOES NOT INHIBIT THE CYTOTOXIC EFFECTS OF A BROAD RANGE OF STANDARD ANTICANCER DRUGS AGAINST HUMAN OVARIAN AND BREAST-CANCER CELLS

      European journal of cancer
    79. MALVIYA VK; LIU PY; GOLDBERG DA; HANTEL A; OTOOLE RV; ROACH RW; CONRAD ME; ALBERTS DS
      A PHASE-II TRIAL OF PIROXANTRONE IN ENDOMETRIAL CANCER - SOUTHWEST-ONCOLOGY-GROUP STUDY-8918

      Anti-cancer drugs
    80. VALCIC S; TIMMERMANN BN; ALBERTS DS; WACHTER GA; KRUTZSCH M; WYMER J; GUILLEN JM
      INHIBITORY EFFECT OF 6 GREEN TEA CATECHINS AND CAFFEINE ON THE GROWTHOF 4 SELECTED HUMAN TUMOR-CELL LINES

      Anti-cancer drugs
    81. ROTHENBERG ML; MOORE MJ; CRIPPS MC; ANDERSEN JS; PORTENOY RK; BURRIS HA; GREEN MR; TARASSOFF PG; BROWN TD; CASPER ES; STORNIOLO AM; VONHOFF DD; ALBERTS DS; WOLFF R; KELSEN DP; KOCHA W; HALLER DG; MODIANOREVAH M; MOORE M; OKEN MM; SCHILSKY RL; SHAH A
      A PHASE-II TRIAL OF GEMCITABINE IN PATIENTS WITH 5-FU-REFRACTORY PANCREAS CANCER

      Annals of oncology
    82. YEILDING A; BERTOLI L; EISENBERG P; PLEZIA P; MODIANO MR; ALBERTS DS; KHOJASTEH A; CRAMER MB; HAHNE WF
      ANTIEMETIC EFFICACY OF 2 DIFFERENT SINGLE INTRAVENOUS DOSES OF DOLASETRON IN PATIENTS RECEIVING HIGH-DOSE CISPLATIN-CONTAINING CHEMOTHERAPY

      American journal of clinical oncology
    83. DORR RT; DVORAKOVA K; SNEAD K; ALBERTS DS; SALMON SE; PETTIT GR
      ANTITUMOR-ACTIVITY OF COMBRETASTATIN-A4 PHOSPHATE, A NATURAL PRODUCT TUBULIN INHIBITOR

      Investigational new drugs
    84. THOMPSON FH; NELSON MA; TRENT JM; GUAN XY; LIU Y; YANG JM; EMERSON J; ADAIR L; WYMER J; BALFOUR C; MASSEY K; WEINSTEIN R; ALBERTS DS; TAETLE R
      AMPLIFICATION OF 19Q13.1-Q13.2 SEQUENCES IN OVARIAN-CANCER - G-BAND, FISH, AND MOLECULAR STUDIES

      Cancer genetics and cytogenetics
    85. GENSLER HL; TIMMERMANN BN; VALCIC S; WACHTER GA; DORR R; DVORAKOVA K; ALBERTS DS
      PREVENTION OF PHOTOCARCINOGENESIS BY TOPICAL ADMINISTRATION OF PURE EPIGALLOCATECHIN GALLATE ISOLATED FROM GREEN TEA

      Nutrition and cancer
    86. ALBERTS DS; GOLDMAN R; XU MJ; DORR RT; QUINN J; WELCH K; GUILLENRODRIGUEZ J; AICKIN M; PENG YM; LOESCHER L; GENSLER H
      DISPOSITION AND METABOLISM OF TOPICALLY ADMINISTERED ALPHA-TOCOPHEROLACETATE - A COMMON INGREDIENT OF COMMERCIALLY AVAILABLE SUNSCREENS AND COSMETICS

      Nutrition and cancer
    87. BROOKS DJ; ALBERTS DS
      A PHASE-I STUDY OF ETOPOSIDE PHOSPHATE PLUS PACLITAXEL

      Seminars in oncology
    88. ALBERTS DS
      INTRODUCTION - APPLICATIONS OF AMIFOSTINE IN CANCER-TREATMENT

      Seminars in oncology
    89. ALBERTS DS; BLEYER WA
      FUTURE-DEVELOPMENT OF AMIFOSTINE IN CANCER-TREATMENT

      Seminars in oncology
    90. MUGGIA FM; LIU PY; ALBERTS DS; WALLACE DL; OTOOLE RV; TERADA KY; FRANKLIN EW; HERRER GW; GOLDBERG DA; HANNIGAN EV
      INTRAPERITONEAL MITOXANTRONE OR FLOXURIDINE - EFFECTS ON TIME-TO-FAILURE AND SURVIVAL IN PATIENTS WITH MINIMAL RESIDUAL OVARIAN-CANCER AFTER 2ND-LOOK LAPAROTOMY - A RANDOMIZED PHASE-II STUDY BY THE SOUTHWEST-ONCOLOGY-GROUP

      Gynecologic oncology
    91. ALBERTS DS; LIU PY; HANNIGAN EV; OTOOLE R; WILLIAMS SD; YOUNG JA; FRANKLIN EW; CLARKEPEARSON DL; MALVIYA VK; DUBESHTER B; ADELSON MD; HOSKINS WJ
      INTRAPERITONEAL CISPLATIN PLUS INTRAVENOUS CYCLOPHOSPHAMIDE VERSUS INTRAVENOUS CISPLATIN PLUS INTRAVENOUS CYCLOPHOSPHAMIDE FOR STAGE-III OVARIAN-CANCER

      The New England journal of medicine
    92. SAMI SM; DORR RT; SOLYOM AM; ALBERTS DS; IYENGAR BS; REMERS WA
      6-SUBSTITUTED AND 7-SUBSTITUTED 1,2-DIHYDRO-3H-DIBENZ[DE,H]ISOQUINOLINE-1,3-DIONES - SYNTHESIS, NUCLEOPHILIC DISPLACEMENTS, ANTITUMOR-ACTIVITY, AND QUANTITATIVE STRUCTURE-ACTIVITY-RELATIONSHIPS

      Journal of medicinal chemistry
    93. SAMI SM; DORR RT; ALBERTS DS; SOLYOM AM; REMERS WA
      1,2-DIHYDRO-3H-DIBENZ[DE,H]ISOQUINOLINE-1,3-DIONES WITH SUBSTITUENTS AT POSITION-4, POSITION-8, POSITION-9, POSITION-10, AND POSITION-11 - SYNTHESIS, ANTITUMOR-ACTIVITY, AND QUANTITATIVE STRUCTURE-ACTIVITY-RELATIONSHIPS

      Journal of medicinal chemistry
    94. ALBERTS DS; LIPKIN M; LEVIN B
      GENETIC SCREENING FOR COLORECTAL-CANCER AND INTERVENTION

      International journal of cancer
    95. BROOKS DJ; WOODWARD S; THOMPSON FH; DOSSANTOS B; RUSSELL M; YANG JM; GUAN XY; TRENT J; ALBERTS DS; TAETLE R
      EXPRESSION OF THE ZINC-FINGER GENE EVI-1 IN OVARIAN AND OTHER CANCERS

      British Journal of Cancer
    96. ALBERTS DS; HEDDENS DK; GARCIA DJ; WILLIAMS SD; HANNIGAN EV; HOSKINS WJ; OTOOLE R; QUADE J; OSULLIVAN J
      CHEMOTHERAPY-INDUCED ANEMIA AND PACKED RED-BLOOD-CELL (PRBC) TRANSFUSIONS IN ADVANCED OVARIAN-CANCER PATIENTS ENROLLED IN A PHASE-III STUDYOF CISPLATIN PLUS CYCLOPHOSPHAMIDE

      Blood
    97. ALBERTS DS; RITENBAUGH C; STORY JA; AICKIN M; REESMCGEE S; BULLER MK; ATWOOD J; PHELPS J; RAMANUJAM PS; BELLAPRAVALU S; PATEL J; BETTINGER L; CLARK L
      RANDOMIZED, DOUBLE-BLINDED, PLACEBO-CONTROLLED STUDY OF EFFECT OF WHEAT BRAN FIBER AND CALCIUM ON FECAL BILE-ACIDS IN PATIENTS WITH RESECTED ADENOMATOUS COLON POLYPS

      Journal of the National Cancer Institute
    98. FINLEY PR; BOGERT CL; ALBERTS DS; EINSPAHR J; EARNEST DL; BLACKWELL G; GIRODIAS K
      MEASUREMENT OF PROSTAGLANDIN E(2) IN RECTAL MUCOSA IN HUMAN-SUBJECTS - A METHOD STUDY

      Cancer epidemiology, biomarkers & prevention
    99. CHILDERS JM; CHU J; VOIGT LF; FEIGL P; TAMIMI HK; FRANKLIN EW; ALBERTS DS; MEYSKENS FL
      CHEMOPREVENTION OF CERVICAL-CANCER WITH FOLIC-ACID - A PHASE-III SOUTHWEST-ONCOLOGY-GROUP INTERGROUP STUDY

      Cancer epidemiology, biomarkers & prevention
    100. ALBERTS DS; KRUTZSCH M; WYMER J; SPEICHER L; CAPIZZI RL
      EVALUATION OF EFFECT OF THE ACTIVE METABOLITE OF AMIFOSTINE (AMI), WR-1065, ON THE CYTOTOXICITY OF ANTICANCER DRUGS AGAINST HUMAN OVARIAN-CANCER

      European journal of cancer


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 18/01/21 alle ore 22:08:31